What's in SIFI SpA's pipeline?

SIFI SpA has 6 drugs in our index: 0 marketed, 0 filed, 5 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with SIFI SpA's portfolio?

Top competitors by shared drug class: , Armata Pharmaceuticals, Inc., Bausch & Lomb Incorporated, Fresenius Kabi, Krishnadevaraya College of Dental Sciences & Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sifi-spa.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

SIFI SpA — Portfolio Competitive Intelligence Brief

SIFI SpA pipeline: 0 marketed, 0 filed, 5 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 5 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Propamidine 0.1%	Propamidine 0.1%	phase 3	Antiprotozoal		Infectious Diseases
PHMB 0.08%	PHMB 0.08%	phase 3	Antimicrobial		Dermatology
NETILDEX™ eye drops solution	NETILDEX™ eye drops solution	phase 3	Antibiotic/corticosteroid combination	Bacterial 30S ribosome (netilmicin); glucocorticoid receptor (dexamethasone)	Ophthalmology
PHMB 0.02%	PHMB 0.02%	phase 3	Antimicrobial agent	Bacterial and fungal cell membranes	Ophthalmology / Antimicrobial
NETILDEX™ ophthalmic gel	NETILDEX™ ophthalmic gel	phase 3	Antibiotic/corticosteroid combination	Bacterial 30S ribosomal subunit (netilmicin); glucocorticoid receptor (dexamethasone)	Ophthalmology

Therapeutic area mix

Ophthalmology · 2
Dermatology · 1
Infectious Diseases · 1
Ophthalmology / Antimicrobial · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

· 1 shared drug class
Armata Pharmaceuticals, Inc. · 1 shared drug class
Bausch & Lomb Incorporated · 1 shared drug class
Fresenius Kabi · 1 shared drug class
Krishnadevaraya College of Dental Sciences & Hospital · 1 shared drug class
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 1 shared drug class
NovaBay Pharmaceuticals, Inc. · 1 shared drug class
Riyadh Colleges of Dentistry and Pharmacy · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for SIFI SpA:

Cite this brief

Drug Landscape (2026). SIFI SpA — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sifi-spa. Accessed 2026-05-14.